2/3
08:03 am
tbph
Theravance Biopharma (NASDAQ:TBPH) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $40.00 price target on the stock.
Low
Report
Theravance Biopharma (NASDAQ:TBPH) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $40.00 price target on the stock.
1/24
05:10 am
tbph
Theravance Biopharma (NASDAQ:TBPH) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Theravance Biopharma (NASDAQ:TBPH) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
1/3
01:08 am
tbph
Theravance Biopharma (NASDAQ:TBPH) was downgraded by analysts at
Wall St
Low
Report
Theravance Biopharma (NASDAQ:TBPH) was downgraded by analysts at
Wall St
12/14
01:27 am
tbph
Theravance Biopharma (NASDAQ:TBPH) was upgraded by analysts at
Wall Stre
Medium
Report
Theravance Biopharma (NASDAQ:TBPH) was upgraded by analysts at
Wall Stre
12/12
09:35 am
tbph
Why The Narrative Around Theravance Biopharma Is Shifting After Trelegy Monetization And Strategic Review [Yahoo! Finance]
Low
Report
Why The Narrative Around Theravance Biopharma Is Shifting After Trelegy Monetization And Strategic Review [Yahoo! Finance]
12/6
01:36 am
tbph
Theravance Biopharma (NASDAQ:TBPH) was downgraded by analysts at
Wall St
Medium
Report
Theravance Biopharma (NASDAQ:TBPH) was downgraded by analysts at
Wall St
12/5
07:03 pm
tbph
Why Theravance Biopharma (TBPH) is a Top Growth Stock for the Long-Term [Yahoo! Finance]
Medium
Report
Why Theravance Biopharma (TBPH) is a Top Growth Stock for the Long-Term [Yahoo! Finance]
12/3
07:02 am
tbph
Theravance Biopharma (NASDAQ:TBPH) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating on the stock.
Low
Report
Theravance Biopharma (NASDAQ:TBPH) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating on the stock.
11/26
08:05 am
tbph
Theravance Biopharma (NASDAQ:TBPH) had its price target raised by analysts at BTIG Research from $25.00 to $40.00. They now have a "buy" rating on the stock.
Medium
Report
Theravance Biopharma (NASDAQ:TBPH) had its price target raised by analysts at BTIG Research from $25.00 to $40.00. They now have a "buy" rating on the stock.
11/23
02:11 am
tbph
Theravance Biopharma (NASDAQ:TBPH) was upgraded by analysts at
Wall Stre
Low
Report
Theravance Biopharma (NASDAQ:TBPH) was upgraded by analysts at
Wall Stre
11/20
11:36 am
tbph
Theravance Biopharma to Host Virtual KOL Investor Event to Review Ampreloxetine Phase 3 Clinical Development Program, Ahead of Topline Data in Q1 2026, on December 8, 2025 [Yahoo! Finance]
Low
Report
Theravance Biopharma to Host Virtual KOL Investor Event to Review Ampreloxetine Phase 3 Clinical Development Program, Ahead of Topline Data in Q1 2026, on December 8, 2025 [Yahoo! Finance]
11/20
11:00 am
tbph
Theravance Biopharma to Host Virtual KOL Investor Event to Review Ampreloxetine Phase 3 Clinical Development Program, Ahead of Topline Data in Q1 2026, on December 8, 2025
Low
Report
Theravance Biopharma to Host Virtual KOL Investor Event to Review Ampreloxetine Phase 3 Clinical Development Program, Ahead of Topline Data in Q1 2026, on December 8, 2025
11/19
06:42 am
tbph
Theravance Biopharma to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Medium
Report
Theravance Biopharma to Participate in Upcoming Investor Conferences [Yahoo! Finance]
11/19
06:00 am
tbph
Theravance Biopharma to Participate in Upcoming Investor Conferences
Medium
Report
Theravance Biopharma to Participate in Upcoming Investor Conferences
11/13
02:20 am
tbph
Here's Why Shares in Theravance Biopharma Exploded Today [Yahoo! Finance]
Low
Report
Here's Why Shares in Theravance Biopharma Exploded Today [Yahoo! Finance]
11/11
08:09 am
tbph
Theravance Biopharma (NASDAQ:TBPH) had its price target raised by analysts at HC Wainwright from $15.00 to $20.00. They now have a "buy" rating on the stock.
High
Report
Theravance Biopharma (NASDAQ:TBPH) had its price target raised by analysts at HC Wainwright from $15.00 to $20.00. They now have a "buy" rating on the stock.
11/11
04:06 am
tbph
Theravance Biopharma, Inc. (TBPH) Q3 2025 Earnings Call Transcript [Seeking Alpha]
High
Report
Theravance Biopharma, Inc. (TBPH) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/10
04:32 pm
tbph
Theravance Biopharma, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
High
Report
Theravance Biopharma, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
11/10
04:17 pm
tbph
Theravance Biopharma GAAP EPS of $0.07 beats by $0.20, revenue of $19.99M beats by $0.1M [Seeking Alpha]
High
Report
Theravance Biopharma GAAP EPS of $0.07 beats by $0.20, revenue of $19.99M beats by $0.1M [Seeking Alpha]
11/10
04:05 pm
tbph
Theravance Biopharma, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update
High
Report
Theravance Biopharma, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update